Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury

Abstract

BackgroundMicroglial activation and the subsequent inflammatory response in the central nervous system play important roles in secondary damage after traumatic brain injury (TBI). High-mobility group box 1 (HMGB1) protein, an important mediator in late inflammatory responses, interacts with transmembrane receptor for advanced glycation end products (RAGE) and toll-like receptors (TLRs) to activate downstream signaling pathways, such as the nuclear factor (NF)-κB signaling pathway, leading to a cascade amplification of inflammatory responses, which are related to neuronal damage after TBI. Omega-3 polyunsaturated fatty acid (ω-3 PUFA) is a commonly used clinical immunonutrient, which has antioxidative and anti-inflammatory effects. However, the effects of ω-3 PUFA on HMGB1 expression and HMGB1-mediated activation of the TLR4/NF-κB signaling pathway are not clear.MethodsThe Feeney DM TBI model was adopted to induce brain injury in rats. Modified neurological severity scores, brain water content, and Nissl staining were employed to determine the neuroprotective effects of ω-3 PUFA supplementation. Assessment of microglial activation in lesioned sites and protein markers for proinflammatory, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, interferon (IFN)-γ, and HMGB1 were used to evaluate neuroinflammatory responses and anti-inflammation effects of ω-3 PUFA supplementation. Immunofluorescent staining and western blot analysis were used to detect HMGB1 nuclear translocation, secretion, and HMGB1-mediated activation of the TLR4/NF-κB signaling pathway to evaluate the effects of ω-3 PUFA supplementation and gain further insight into the mechanisms underlying the development of the neuroinflammatory response after TBI.ResultsIt was found that ω-3 PUFA supplementation inhibited TBI-induced microglial activation and expression of inflammatory factors (TNF-α, IL-1β, IL-6, and IFN-γ), reduced brain edema, decreased neuronal apoptosis, and improved neurological functions after TBI. We further demonstrated that ω-3 PUFA supplementation inhibited HMGB1 nuclear translocation and secretion and decreased expression of HMGB1 in neurons and microglia in the lesioned areas. Moreover, ω-3 PUFA supplementation inhibited microglial activation and the subsequent inflammatory response by regulating HMGB1 and the TLR4/NF-κB signaling pathway.ConclusionsThe results of this study suggest that microglial activation and the subsequent neuroinflammatory response as well as the related HMGB1/TLR4/NF-κB signaling pathway play essential roles in secondary injury after TBI. Furthermore, ω-3 PUFA supplementation inhibited TBI-induced microglial activation and the subsequent inflammatory response by regulating HMGB1 nuclear translocation and secretion and also HMGB1-mediated activation of the TLR4/NF-κB signaling pathway, leading to neuroprotective effects.

Melatonin and inflammation—Story of a double‐edged blade

“…A specific aspect of TLR4 activation concerns the binding of HMGB1 (high‐mobility group box‐1), which acts as an inflammatory signal released by, for example, monocytes, macrophages, endothelial and several other cells. In a number of studies, SIRT1 has been shown to deacetylate HMGB1, to decrease expression, nucleocytoplasmic transfer and release of this protein . Similar findings on anti‐inflammatory actions via HMGB1 inhibition have been obtained with melatonin .…”

S100A8 Promotes Inflammation via Toll-Like Receptor 4 After Experimental Traumatic Brain Injury

“…Previous studies have demonstrated that TLRs could trigger in ammation through activation of NF-κB, and subsequent upregulation of pro-in ammatory cytokine expression. [35] It was revealed that NF-κB was involved in the development of in ammation in S100A8/A9-stimulated BV-2 cells [17]. We hypothesized that NF-κB could act as the downstream node of TLR4-MyD88 dependent pathway after TBI.…”

Traumatic Brain Injury and Blood–Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid Condition

“…Increased LC3-II and autophagosomes are observed in the experimental weight drop injury model of TBI [67], and caloric restriction after mild TBI results in increased Beclin 1, LC3, and mTOR [68]. TBI could inhibit PI3K/AKT/mTOR pathway [69], NRF2/ARE pathway [50], TLR4/NF-κB pathway [70], and activate FoxO3a [71] and Drp1 [72] proteins, which are in the upstream of autophagy and their regulation by TBI may promote autophagosome formation and cause BBB disruption [66].…”